Call Us @ 0172 - 4680800 | info@indswift.com | NETWORKS | NSE - BSE

Investors

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER'2012
(Rs. In lacs.)
PARTICULARS
QUARTER ENDED PERIOD ENDED
 (UNAUDITED)(AUDITED)(UNAUDITED)(AUDITED)
 30.09.1230.06.1230.09.1130.06.12
   (15 Months)
INCOME FROM OPERATIONS16356.1439266.1824315.89159046.56
TOTAL INCOME FROM OPERATIONS16356.1439266.1824315.89159046.56
EXPENDITURE   
COST OF MATERIALS CONSUMED11016.2121086.9421387.37121257.34
CHANGE IN INVENTORIES F.G./W.I.P809.0220250.09-3246.9914476.40
EMPLOYEES BENEFIT EXPENSES1459.06-324.17953.883948.08
DEPRECIATION/AMORTISATION704.34566.79404.842324.93
OTHER EXPENDITURE2310.501943.391844.7010260.45
TOTAL EXPENDITURE16299.1343523.0421343.80152267.20
PROFIT FROM OPERATIONS57.01-4256.862972.096779.36
OTHER INCOME223.30120.78267.702932.28
PROFIT BERORE FINANCE COST280.31-4136.083239.799711.64
FINANCE COST3013.292837.612122.6012096.70
PROFIT BEFORE TAX-2732.98-6973.691117.19-2385.06
PROVISION FOR TAX0.000.00223.550.00
MAT CREDIT ENTITLEMENT0.00 0.00 (223.55)0.00
PROVISION FOR DEFFERED TAX0.00-683.5425.00-283.54
ADD INCOME TAX PREV. YEAR ADJ.0.000.000.000.00
NET PROFIT-2732.98-6290.151092.19-2101.52
PAID UP EQUITY SHARE CAPITAL Rs. 2/- EACH923.57923.57843.57923.57
RESERVE EXCLUDING REVALUATION RESERVES  29464.34
EARNING PER SHARE RS. 2/-EACH   
BASIC-5.92-13.622.59-4.84
DILUTED-5.92-12.792.22-4.27
A) PARTICULARS OF SHAREHOLDING   
Public Shareholding   
No. of Shares23790064237900642379006423790064
% of shareholding51.5251.5256.4051.52
Promoters & Promoters group Shareholding    
a) Pledged/ encumbereredNilNilNilNil
- No. of SharesNilNilNilNil
- % of shares (as a % of the total shareholding of    
promoter & promoter groupNilNilNilNil
- % of shares( as a % of the total share capital of the    
CompanyNilNilNilNil
b) Non- Encumbered   
- No. of Shares22388306223883061838830622388306
-% of shares (as a % of the total shareholding of    
promoter & promoter group100100100100
- % of shares( as a % of the total share capital of the    
company48.4848.4843.6048.48
ParticularsQtr ended 
B) INVESTOR COMPLAINTS30.09.2012
Pending at the beginning of the Quarter0
Received during the quarter2
Disposed of during the quarter2
Remaining unresolved at the end of the quarter0
Notes:-
1. The company has also diversified into Dairy segment in addition to the Pharmaceuticals.As the revenue from the 
 dairy segment is less than 10% of Total income of the company, hence separete segment reporting has not been given.
2. Previous year figures have been re-grouped/ Re- arranged where ever necessary.
3. The above results have been taken into record by the Audit Committee and Board of Directors of the company in 
   their respective meetings held on 7th November 2012.
Place: Chandigarh By the order of the Board of Directors
Date: 7th November 2012(S.R.Mehta)
Chairman